The Treatment of Genetic Disease

[1]  S. Ellard,et al.  Treatment of genetic disease , 2007 .

[2]  Edward A Copelan,et al.  Hematopoietic stem-cell transplantation. , 2006, The New England journal of medicine.

[3]  Ronald G. Crystal,et al.  Genetic medicines: treatment strategies for hereditary disorders , 2006, Nature Reviews Genetics.

[4]  J. Rasko,et al.  Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response , 2006, Nature Medicine.

[5]  W. Hauswirth,et al.  Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  K. Weinberg,et al.  Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID). , 2005, Clinical immunology.

[7]  K. Weinberg.  Early use of drastic therapy. , 2005, New England Journal of Medicine.

[8]  S. Schrier,et al.  New strategies in the treatment of the thalassemias. , 2005, Annual review of medicine.

[9]  A. Fischer,et al.  Gene therapy for severe combined immunodeficiency. , 2005, Annual review of medicine.

[10]  Christine Kinnon,et al.  Mutations in TNFRSF13B Encoding TACI Are Associated With Common Variable Immunodeficiency in Humans , 2006, Pediatrics.

[11]  M. Stevenson.  Therapeutic potential of RNA interference , 2004, The New England journal of medicine.

[12]  R. Nagel,et al.  Sickle-cell disease , 2004, The Lancet.

[13]  R. Sandhaus.  α1-Antitrypsin deficiency · 6: New and emerging treatments for α1-antitrypsin deficiency , 2004, Thorax.

[14]  G. Pellegrini.  Changing the cell source in cell therapy? , 2004, The New England journal of medicine.

[15]  Y. Saunthararajah,et al.  DNA hypo‐methylating agents and sickle cell disease , 2004, British journal of haematology.

[16]  P. Zeitlin.  Can curcumin cure cystic fibrosis? , 2004, The New England journal of medicine.

[17]  H. Paulson,et al.  RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia , 2004, Nature Medicine.

[18]  J. Muenzer,et al.  Advances in the treatment of mucopolysaccharidosis type I. , 2004, The New England journal of medicine.

[19]  M. Poe,et al.  Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. , 2004, The New England journal of medicine.

[20]  R. Desnick,et al.  Enzyme replacement and enhancement therapies for lysosomal diseases , 2004, Journal of Inherited Metabolic Disease.

[21]  G. Daley,et al.  Nuclear transplantation, embryonic stem cells and the potential for cell therapy. , 2003, The hematology journal : the official journal of the European Haematology Association.

[22]  G. Lukács,et al.  Pharmacologic approaches to correcting the basic defect in cystic fibrosis. , 2003, The New England journal of medicine.

[23]  Z. Estrov,et al.  Adult stem cells for tissue repair - a new therapeutic concept? , 2003, The New England journal of medicine.

[24]  Mark A. Kay,et al.  Progress and problems with the use of viral vectors for gene therapy , 2003, Nature Reviews Genetics.

[25]  K. High.  The risks of germline gene transfer. , 2003, The Hastings Center report.

[26]  P. Kaplan,et al.  Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry. , 2002, The American journal of medicine.

[27]  A. Mortellaro,et al.  Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative Conditioning , 2002, Science.

[28]  Jean Bennett,et al.  Gene therapy restores vision in a canine model of childhood blindness , 2001, Nature Genetics.

[29]  I. Weissman,et al.  Translating stem and progenitor cell biology to the clinic: barriers and opportunities. , 2000, Science.

[30]  T. Hollon.  Researchers and regulators reflect on first gene therapy death , 2000, Nature Medicine.

[31]  D. Kelly,et al.  Current results and evolving indications for liver transplantation in children. , 1998, Journal of pediatric gastroenterology and nutrition.

[32]  J. Wagner,et al.  Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. , 1998, The New England journal of medicine.

[33]  P. Lane.  Sickle cell disease. , 1996, Pediatric clinics of North America.

[34]  B. Childs,et al.  Response to treatment in hereditary metabolic disease: 1993 survey and 10-year comparison. , 1995, American journal of human genetics.

[35]  T. Starzl,et al.  Liver transplantation: a 31-year perspective. Part I. , 1990, Current problems in surgery.

[36]  B. Childs,et al.  The effect of Mendelian disease on human health. II: Response to treatment. , 1985, American journal of medical genetics.